Ibis | GenomeWeb

Ibis

The California Institute of Technology has been awarded

Rosetta Genomics has been awarded

Philips has been awarded

Du Pont has been awarded

CHICAGO (GenomeWeb) — Abbott continues to grow its molecular product line, previewing the next generation of its pathogen identification platform at the American Association for Clinical Chemistry annual meeting here this week.

NEW YORK (GenomeWeb) — A recent case study has shown the utility of combined PCR/electrospray ionization mass spectrometry (PCR/ESI-MS) for detecting a rare pathogen in a case of meningitis.

Lawrence Livermore National Security and The University of California have been awarded US Patent No.

A Mayo Clinic research group that previously evaluated Abbott's PCR-electrospray ionization mass spectrometry platform to broadly identify fungal infections has now published research demonstrating the system's ability to identify Mycobacterium species and M.

Researchers from the Mayo Clinic have demonstrated that Abbott's Plex-ID broad fungal assay is as good or in some cases better than culture-based methods for identifying fungal infections to the species level directly from respiratory specimens without prior knowledge of the offending orga

Ibis Biosciences (Abbott) has been awarded US Patent No. 8,407,010, "Methods for rapid forensic analysis of mitochondrial DNA."
Steven Hofstadler, Thomas Hall, David Ecker, Lawrence Blyn, Mark Eshoo, Vivek Samant, and Neill White are named as inventors.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.